Women with breast cancer can experience persisting cognitive deficits post treatment. We
conducted a multilevel meta-analysis of cognitive function in survivors treated with …

Doxorubicin is a leading chemotherapeutic halting cellular replication and inducing p53-
dependent apoptosis in cancerous tissue. Like many chemotherapies, doxorubicin damages …

Purpose The aim of this review is to provide an updated overview of chemotherapy-related
cognitive impairment (CRCI) in patients with cancer outside central nervous system (CNS) …

Among the potential adverse effects of breast cancer treatment, chemotherapy-related
cognitive impairment (CRCI) has gained increased attention in the past years. In this review …

ABSTRACT Chemotherapy-Related Cognitive Impairment (CRCI) can be an adverse effect
in women treated for breast cancer. Some longitudinal studies reported deficits in attention …

Background: Chemotherapy-related cognitive impairment (CRCI), or “chemobrain,”
isdefined as a phenomenon of cognitive deficits in cancer patients after chemotherapy and …

Chemotherapy is one of the most widely used treatments for breast cancer (BC). However,
there is evidence of side effects like cognitive changes related to the chemotherapy …

The present study explores whether SVD affects bimanual coordination, which is easier to
detect than by conventional, MRI-based methods. We tested nine severe SVD patients, eight …

Background Previous findings indicated that breast cancer patients often have dysfunction in
empathy and other cognitive functions during or after chemotherapy. However, the …

According to the Centers for Disease Control and Prevention each year about 650,000
Americans with cancer undergo potentially lifesaving treatments usually via some …